Strategy purchased another $75.3 million in Bitcoin, executive chairman Michael Saylor announced on Monday. Illustration: Gwen P; Source: ShutterstockStrategy purchased another $75.3 million in Bitcoin, executive chairman Michael Saylor announced on Monday. Illustration: Gwen P; Source: Shutterstock

Strategy adds $75m more Bitcoin as traders hedge for $70,000 price

2026/02/03 16:56
3 min read

Strategy purchased another $75.3 million in Bitcoin, executive chairman Michael Saylor announced on Monday.

The crypto treasury firm now holds just over $54 billion in Bitcoin purchased at an average price of $76,052 per coin.

Plenty of other Bitcoin believers are buying the dip as well.

Investors poured $562 million into spot Bitcoin exchange-traded funds on Monday, according to DefiLlama data.

The buying spree comes as Bitcoin’s price has been hammered by over 15% in the past month, due in part to market uncertainty and geopolitical unrest.

That chaos cocktail includes US President Donald Trump’s nomination of interest rate hawk Kevin Warsh as the next Federal Reserve boss, ongoing tariff threats, the fatal shootings in Minneapolis, and Trump’s seeming indifference toward a weaker dollar.

Crypto bloodbath

Warsh’s nomination is a major U-turn by Trump, who has long insisted on lower interest rates. A hawkish Fed means fewer and slower rate cuts, meaning less money in the financial system to boost asset prices like Bitcoin, stocks, or gold.

To be sure, Warsh still needs to be confirmed by the Senate, and consensus on interest rates must be reached with other Fed governors.

“Investors turned bearish after news about new US Federal Reserve leadership appointments, raising fears that monetary policy could remain tighter for longer,” Erikka Arone, senior vice-president at crypto-trading platform sFOX, told DL News.

Bitcoin is trading 38% below its all-time high and has lagged behind other assets, such as stocks and gold, since the $1 trillion October wipeout.

“It’s been a bloodbath across crypto markets over the past few days,” Nick Forster, founder of Derive.xyz, said in an investor note shared with DL News.

He said that traders are now positioning for a drop to as low as $70,000 per Bitcoin.

“Short-term fear is dominating market psychology,” he said. “This reflects acute uncertainty in the immediate term.”

And Forster is far from the only bearish voice.

On Monday, Bloomberg Intelligence strategist Mike McGlone doubled down on his $10,000 prediction for Bitcoin.

Crypto market movers

  • Bitcoin is up 2.3% over the past 24 hours, trading at $78,761.
  • Ethereum is up 3% past 24 hours at $2,317.

What we’re reading

  • What is Moltbook? Memecoin tied to AI bot forum crashes 75% after X hype — DL News
  • Iranians tap decentralised networks to reveal depths of chaos as thousands revolt: ‘Living in hell’ — DL News
  • Bitcoin Sinks as Markets Price In a More Hawkish Fed — Unchained
  • The ABCD investing framework — Milk Road
  • Bitcoin price to $10,000 as markets barrel towards crash ‘reminiscent of 2008,’ Bloomberg analyst warns — DL News

Lance Datskoluo is DL News’ Europe-based markets correspondent. Got a tip? Email him at lance@dlnews.com.

Disclaimer: The articles reposted on this site are sourced from public platforms and are provided for informational purposes only. They do not necessarily reflect the views of MEXC. All rights remain with the original authors. If you believe any content infringes on third-party rights, please contact service@support.mexc.com for removal. MEXC makes no guarantees regarding the accuracy, completeness, or timeliness of the content and is not responsible for any actions taken based on the information provided. The content does not constitute financial, legal, or other professional advice, nor should it be considered a recommendation or endorsement by MEXC.

You May Also Like

Bitcoin ETFs Outpace Ethereum With $2.9B Weekly Surge

Bitcoin ETFs Outpace Ethereum With $2.9B Weekly Surge

The surge follows a difficult August, when investors pulled out more than $750 million while rotating capital into Ethereum-focused funds. […] The post Bitcoin ETFs Outpace Ethereum With $2.9B Weekly Surge appeared first on Coindoo.
Share
Coindoo2025/09/18 01:15
CME Group to launch options on XRP and SOL futures

CME Group to launch options on XRP and SOL futures

The post CME Group to launch options on XRP and SOL futures appeared on BitcoinEthereumNews.com. CME Group will offer options based on the derivative markets on Solana (SOL) and XRP. The new markets will open on October 13, after regulatory approval.  CME Group will expand its crypto products with options on the futures markets of Solana (SOL) and XRP. The futures market will start on October 13, after regulatory review and approval.  The options will allow the trading of MicroSol, XRP, and MicroXRP futures, with expiry dates available every business day, monthly, and quarterly. The new products will be added to the existing BTC and ETH options markets. ‘The launch of these options contracts builds on the significant growth and increasing liquidity we have seen across our suite of Solana and XRP futures,’ said Giovanni Vicioso, CME Group Global Head of Cryptocurrency Products. The options contracts will have two main sizes, tracking the futures contracts. The new market will be suitable for sophisticated institutional traders, as well as active individual traders. The addition of options markets singles out XRP and SOL as liquid enough to offer the potential to bet on a market direction.  The options on futures arrive a few months after the launch of SOL futures. Both SOL and XRP had peak volumes in August, though XRP activity has slowed down in September. XRP and SOL options to tap both institutions and active traders Crypto options are one of the indicators of market attitudes, with XRP and SOL receiving a new way to gauge sentiment. The contracts will be supported by the Cumberland team.  ‘As one of the biggest liquidity providers in the ecosystem, the Cumberland team is excited to support CME Group’s continued expansion of crypto offerings,’ said Roman Makarov, Head of Cumberland Options Trading at DRW. ‘The launch of options on Solana and XRP futures is the latest example of the…
Share
BitcoinEthereumNews2025/09/18 00:56
The FDA Is Trying To Make Corporate Free Speech Situational

The FDA Is Trying To Make Corporate Free Speech Situational

The post The FDA Is Trying To Make Corporate Free Speech Situational appeared on BitcoinEthereumNews.com. BENSENVILLE, ILLINOIS – SEPTEMBER 10: Flanked by U.S. Attorney General Pam Bondi (rear), and FDA Commissioner Marty Makary (R), Secretary of Health and Human Services Robert F. Kennedy Jr. speaks to the press outside Midwest Distribution after it was raided by federal agents on September 10, 2025 in Bensenville, Illinois. According to the company, various e-liquids were seized in the raid. (Photo by Scott Olson/Getty Images) Getty Images While running for President in 2008, Barack Obama famously chanted “Yes we can.” Love or hate his political views, Obama’s politics were quite effective. He was asking voters to think big, to envision a much better future. Advertisers no doubt approved. That’s because ads routinely evoke things not as they are, but as they could be. Gyms and exercise equipment companies don’t promote their locations and equipment with flabby, lumbering people, rather their ads show fit, upright, energetic individuals. A look ahead. Restaurants do the same with ads showing happy people enjoying impressively put together plates of food. Conversely, ads meant to convince smokers to quit have not infrequently shown the worst of the worst future downsides of the habit. The nature of advertising comes to mind as FDA commissioner Marty Makary puzzlingly brags that “The Trump Administration Is Taking On Big Pharma” in the New York Times. Makary laments pharmaceutical ads that “are filled with dancing patients, glowing smiles and catch jingles that drown out the fine print.” Not explained is whether Makary would be happier if drug companies placed ads with immobile patients, frowns, and funereal music. Seriously, what does he expect? Does he want drug companies to commit billions to drug development to accompany their achievements with imagery defined by misery? Has Makary stopped to contemplate the myriad shareholders lawsuits drugmakers would face if, upon risking staggering sums meant…
Share
BitcoinEthereumNews2025/09/18 06:29